$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs

$pavs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 20-F Financial Statement

#000121390023060263 Filed on July 27, 2023

Income Statement

Concept	2023 Q1	2023	2022
Revenue	$45.16M	$98.15M	$89.49M
YoY Change	6.0%	9.68%	25.19%
Cost Of Revenue	$42.64M	$93.10M	$85.78M
YoY Change	-4.32%	8.54%	60.91%
Gross Profit	$2.520M	$5.054M	$3.711M
YoY Change	-228.37%	36.18%	-79.58%
Gross Profit Margin	5.58%	5.15%	4.15%
Selling, General & Admin	$42.53M	$64.18M	$49.60M
YoY Change	24.41%	29.39%	230.91%
% of Gross Profit	1687.7%	1269.78%	1336.49%
Research & Development	$990.0K	$1.397M	$1.684M
YoY Change	10.66%	-17.04%	1.45%
% of Gross Profit	39.29%	27.64%	45.38%
Depreciation & Amortization	$1.870M	$1.615M	$1.553M
YoY Change	11.99%	3.98%	82.87%
% of Gross Profit	74.21%	31.96%	41.85%
Operating Expenses	$43.52M	$73.45M	$61.60M
YoY Change	24.06%	19.24%	269.96%
Operating Profit	-$41.00M	-$68.39M	-$57.89M
YoY Change	10.68%	18.15%	-3894.01%
Interest Expense	-$20.00K	$72.30K	$85.99K
YoY Change	998.9%	-15.92%	-23.08%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$335.2K	$139.5K
YoY Change	-100.0%	-340.28%	11.04%
Pretax Income	-$48.89M	-$68.73M	-$57.75M
YoY Change	3.25%	19.02%	-3596.94%
Income Tax	$560.0K	$3.457M	-$3.726M
% Of Pretax Income
Net Earnings	-$52.37M	-$71.74M	-$49.19M
YoY Change	33.82%	45.84%	-6355.51%
Net Earnings / Revenue	-115.97%	-73.09%	-54.97%
Basic Earnings Per Share		-$12.63	-$1.22
Diluted Earnings Per Share	-$9.22	-$12.63	-$1.22
COMMON SHARES
Basic Shares Outstanding		5.678M shares	40.49M shares
Diluted Shares Outstanding		5.678M shares	40.49M shares

Balance Sheet

Concept	2023 Q1	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.400M	$3.400M	$19.73M
YoY Change	-82.77%	-82.77%	-46.02%
Cash & Equivalents	$3.355M	$3.400M	$19.73M
Short-Term Investments
Other Short-Term Assets	$263.9K	$4.400M	$7.909M
YoY Change	16.7%	-44.37%	-64.36%
Inventory	$335.0K	$300.0K	$1.390M
Prepaid Expenses
Receivables	$1.706M	$1.700M	$27.45M
Other Receivables	$0.00	$0.00	$89.33K
Total Short-Term Assets	$9.786M	$9.800M	$56.57M
YoY Change	-82.7%	-82.68%	-40.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.470M	$8.500M	$11.25M
YoY Change	-24.69%	-24.42%	6.97%
Goodwill	$6.456M
YoY Change	-35.98%
Intangibles	$9.446M
YoY Change	-6.49%
Long-Term Investments
YoY Change
Other Assets	$2.182M	$2.200M	$9.424M
YoY Change	-61.22%	-76.65%	83.41%
Total Long-Term Assets	$26.55M	$26.50M	$40.86M
YoY Change	-35.01%	-35.14%	131.52%
TOTAL ASSETS
Total Short-Term Assets	$9.786M	$9.800M	$56.57M
Total Long-Term Assets	$26.55M	$26.50M	$40.86M
Total Assets	$36.34M	$36.30M	$97.43M
YoY Change	-62.7%	-62.74%	-13.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.46M	$18.60M	$12.16M
YoY Change	10.75%	53.01%	37.49%
Accrued Expenses			$2.190K
YoY Change			-104.13%
Deferred Revenue
YoY Change
Short-Term Debt	$2.241M	$2.200M	$2.268M
YoY Change	-1.2%	-3.01%	1.4%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.95M	$21.00M	$17.93M
YoY Change	16.85%	17.12%	18.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.95M	$21.00M	$17.93M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$22.47M	$21.60M	$19.30M
YoY Change	12.27%	11.92%	7.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$59.45M
YoY Change	-583.94%
Common Stock	$77.18K
YoY Change	130.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$14.76M	$14.80M	$78.13M
YoY Change
Total Liabilities & Shareholders Equity	$36.34M	$36.30M	$97.43M
YoY Change	-62.7%	-62.74%	-13.59%

Cashflow Statement

Concept	2023 Q1	2023	2022
OPERATING ACTIVITIES
Net Income	-$52.37M	-$71.74M	-$49.19M
YoY Change	33.82%	45.84%	-6355.51%
Depreciation, Depletion And Amortization	$1.870M	$1.615M	$1.553M
YoY Change	11.99%	3.98%	82.87%
Cash From Operating Activities	-$12.89M	-$21.09M	-$28.13M
YoY Change	-63.05%	-25.04%	-1068.67%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	$45.82K	$2.390M
YoY Change	-98.64%	-98.08%	-14.12%
Acquisitions			$691.1K
YoY Change			-92.43%
Other Investing Activities	$120.0K	$140.0K	-$6.069M
YoY Change	-101.98%	-102.31%	-35.35%
Cash From Investing Activities	$160.0K	$89.32K	-$8.477M
YoY Change	-101.94%	-101.05%	-35.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.000M	$18.88M
YoY Change		-84.11%	72.15%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.550M	$3.146M	$18.83M
YoY Change	-90.81%	-83.3%	76.45%
NET CHANGE
Cash From Operating Activities	-12.89M	-$21.09M	-$28.13M
Cash From Investing Activities	160.0K	$89.32K	-$8.477M
Cash From Financing Activities	1.550M	$3.146M	$18.83M
Net Change In Cash	-11.18M	-$16.38M	-$16.83M
YoY Change	-57.48%	-2.66%	-679.38%
FREE CASH FLOW
Cash From Operating Activities	-$12.89M	-$21.09M	-$28.13M
Capital Expenditures	-$30.00K	$45.82K	$2.390M
Free Cash Flow	-$12.86M	-$21.14M	-$30.53M
YoY Change	-60.65%	-30.76%	-25321.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5678081	shares
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	333-230170
CY2023	dei	Entity Registrant Name EntityRegistrantName	Paranovus Entertainment Technology Ltd.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 11, Dongjiao East Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Shuangxi, Shunchang
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Shunchang
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Nanping City
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Security12b Title Security12bTitle	Class A ordinary shares, par value US$0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	PAVS
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	6706
CY2023	dei	Auditor Name AuditorName	TPS Thayer, LLC
CY2023	dei	Auditor Location AuditorLocation	Sugar Land, TX
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3355487	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19733631	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1706279	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27447907	usd
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	89332	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	335019	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	1389561	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4389186	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7909233	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	9785971	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	56569664	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8470272	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11246815	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	9446255	usd
CY2022Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	10101405	usd
CY2023Q1	us-gaap	Goodwill Goodwill	6455781	usd
CY2022Q1	us-gaap	Goodwill Goodwill	10084201	usd
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3796492	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2181930	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5627099	usd
CY2023Q1	us-gaap	Assets Assets	36340209	usd
CY2022Q1	us-gaap	Assets Assets	97425676	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13462008	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12155733	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	5106634	usd
CY2022Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3469768	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	143360	usd
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	37225	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2241076	usd
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2268360	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	20953078	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	17931086	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	1514060	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	2079986	usd
CY2023Q1	us-gaap	Liabilities Liabilities	22467138	usd
CY2022Q1	us-gaap	Liabilities Liabilities	20011072	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	77177	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	33502	usd
CY2023Q1	pavs	Common Stock Value1 CommonStockValue1	6123	usd
CY2022Q1	pavs	Common Stock Value1 CommonStockValue1	6048	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66908726	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53871226	usd
CY2023Q1	pavs	Statutory Surplus Reserve StatutorySurplusReserve	7622765	usd
CY2022Q1	pavs	Statutory Surplus Reserve StatutorySurplusReserve	7622765	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59453593	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	12285281	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-402119	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4306536	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	14759079	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	78125358	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-886008	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	-710754	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13873071	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77414604	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36340209	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	97425676	usd
CY2023	us-gaap	Revenues Revenues	98152825	usd
CY2022	us-gaap	Revenues Revenues	89488658	usd
CY2021	us-gaap	Revenues Revenues	71484703	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	93098463	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	85777192	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	53309102	usd
CY2023	us-gaap	Gross Profit GrossProfit	5054362	usd
CY2022	us-gaap	Gross Profit GrossProfit	3711466	usd
CY2021	us-gaap	Gross Profit GrossProfit	18175601	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	54701318	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	40476616	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9958886	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9478099	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9126812	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5030899	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1397118	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1684089	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1660100	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7872696	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	10309745	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	73449231	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	61597262	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	16649885	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-68394869	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-57885796	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	1525716	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	31886	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	108395	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	131901	usd
CY2023	us-gaap	Interest Expense InterestExpense	72303	usd
CY2022	us-gaap	Interest Expense InterestExpense	85993	usd
CY2021	us-gaap	Interest Expense InterestExpense	111799	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-294750	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	117086	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	105522	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-335167	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	139488	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	125624	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-68730036	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57746308	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1651340	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3457080	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3726227	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	959384	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54020081	usd
CY2021	us-gaap	Profit Loss ProfitLoss	691956	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-448242	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4829471	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-94400	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-71738874	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-49190610	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	786356	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-4435667	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2523258	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	6113570	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-76622783	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-51496823	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	6805526	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	272988	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2696899	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2873378	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76895771	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48799924	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3932148	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.63
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5678081	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40485912	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26160270	shares
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	79589989	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10725700	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	778423	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	112418	usd
CY2021	us-gaap	Profit Loss ProfitLoss	691956	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	375000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	6113570	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	97637056	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18877600	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1086231	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	11310540	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54020081	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	2523258	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	77414604	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6000000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7081250	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-4435667	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13873071	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-54020081	usd
CY2021	us-gaap	Profit Loss ProfitLoss	691956	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3378952	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2187206	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	880879	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	854615	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	463514	usd
CY2023	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1	7872696	usd
CY2022	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1	10407349	usd
CY2023	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment	97552	usd
CY2022	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment	434183	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	383376	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-95932	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3230566	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-3921856	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1086231	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	778423	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24887013	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23222982	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2106752	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-89332	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	88495	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1054542	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-454262	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-389388	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3520047	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-12250088	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8057239	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3445169	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	329926	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1718110	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1306275	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4845854	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6723151	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1636866	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-15213292	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	3134093	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-844718	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	106135	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-317026	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-402825	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21090732	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28134783	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2904466	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45819	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2390339	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2783440	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17165	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1051138	usd
CY2022	pavs	Business Acquisitions Of Hekangyuan BusinessAcquisitionsOfHekangyuan	7998836	usd
CY2022	pavs	Acquisition Of Intangible Assets AcquisitionOfIntangibleAssets	79584	usd
CY2022	pavs	Deposits Return From Shennong DepositsReturnFromShennong	-1931646	usd
CY2021	pavs	Purchase Of Daji PurchaseOfDAJI	75044	usd
CY2021	pavs	Deposits Paid For Business Acquisitions DepositsPaidForBusinessAcquisitions	-9313225	usd
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	23777	usd
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates	34330	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	111364	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	43069	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	89322	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8476879	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13222847	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18877600	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10965553	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	37522	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	375000	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2488467	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2247086	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	2163037	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2342943	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2293900	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	2118893	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3145524	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18830786	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10672219	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1477742	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	955755	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2550149	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16378144	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16825121	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2903987	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19733631	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36558752	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	33654765	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3355487	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19733631	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36558752	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	306090	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	570113	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1209381	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	72303	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	85993	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	111790	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	7386320	usd
CY2023Q1	pavs	Equity Method Investment Ownership Percent EquityMethodInvestmentOwnershipPercent	1	pure
CY2018Q3	pavs	Equity Method Investment Interest Description EquityMethodInvestmentInterestDescription	Mr. Wang Xuezhu and other shareholders of Fujian Happiness transferred their 100% ownership interests in Fujian Happiness to Happiness Fuzhou, which is 100% owned by Happiness Hong Kong. After the reorganization, Paranovus Cayman owns 100% equity interests of Fujian Happiness. Mr. Wang Xuezhu, who owns 52.37% ownership of Paranovus Cayman, became the ultimate controlling shareholder (“the Controlling Shareholder”) of the Company.
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	77223100	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23000000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23000000	shares
CY2023Q1	pavs	Purchase Percentage PurchasePercentage	0.15	pure
CY2022Q4	us-gaap	Public Utilities Approved Return On Equity Percentage PublicUtilitiesApprovedReturnOnEquityPercentage	1	pure
CY2023Q4	us-gaap	Public Utilities Approved Return On Equity Percentage PublicUtilitiesApprovedReturnOnEquityPercentage	1	pure
CY2023	us-gaap	Profit Loss ProfitLoss	-72187116	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets And Liabilities Net IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	11167107	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the consolidated financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, inventory reserve, allowance for credit losses, goodwill impairment, income taxes related to realization of deferred tax assets and uncertain tax position, provisions necessary for contingent liabilities and purchase price allocation in connection with the business combination. The current economic environment has increased the degrees of uncertainty inherent in those estimates and assumptions, actual results could differ from those estimates.</p>
CY2023	pavs	Business Combination Extend Duration BusinessCombinationExtendDuration	P1Y
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1	usd
CY2023	pavs	Sales From Our Product Lines SalesFromOurProductLines	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the years ended March 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Healthcare products</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,770,835</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">30,323,831</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,389,702</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Online store</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">42,201,865</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28,014,109</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,473,626</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Internet information and advertising</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,197,348</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,538,943</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,245,019</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Automobile</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,982,777</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">20,611,775</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,376,356</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">98,152,825</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">89,488,658</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">71,484,703</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2023	us-gaap	Revenues Revenues	98152825	usd
CY2022	us-gaap	Revenues Revenues	89488658	usd
CY2021	us-gaap	Revenues Revenues	71484703	usd
CY2023Q1	us-gaap	Grants Receivable GrantsReceivable	10134	usd
CY2022Q1	us-gaap	Grants Receivable GrantsReceivable	11893	usd
CY2021Q1	us-gaap	Grants Receivable GrantsReceivable	63520	usd
CY2023	pavs	Shipping And Handling Costs ShippingAndHandlingCosts	46950	usd
CY2022	pavs	Shipping And Handling Costs ShippingAndHandlingCosts	291170	usd
CY2021	pavs	Shipping And Handling Costs ShippingAndHandlingCosts	1104120	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	51805596	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	26210291	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5720458	usd
CY2023	pavs	After Tax Profit AfterTaxProfit	0.10	pure
CY2023	pavs	Accumulative Amount Of Reserve AccumulativeAmountOfReserve	0.50	pure
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	463514	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	854615	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	463514	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	854615	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Concentration of Risks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Exchange Rate Risks</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in China, which may give rise to significant foreign currency risks from fluctuations and the degree of volatility of foreign exchange rates between the US$ and the RMB. As of March 31, 2023 and 2022, cash and cash equivalents of $1,825,187 (RMB 12,542,139) and $19,571,668 (RMB 124,244,865), respectively, is denominated in RMB and is held in PRC.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Currency Convertibility Risks</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of the Company’s operating activities are transacted in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People’s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People’s Bank of China. Approval of foreign currency payments by the People’s Bank of China or other regulatory institutions requires submitting a payment application form together with other information such as suppliers’ invoices, shipping documents and signed contracts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risks</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risks consist primarily of cash and cash equivalents and accounts receivable, the balances of which are stated on the consolidated balance sheets which represent the Company’s maximum exposure. The Company places its cash and cash equivalents in good credit quality financial institutions in China. Concentration of credit risks with respect to accounts receivables is linked to the concentration of revenue. To manage credit risk, the Company performs ongoing credit evaluations of customers’ financial condition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Interest Rate Risks</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to interest rate risk. Bank interest bearing loans are charged at variable interest rates within the reporting period. The Company is subject to the risk of adverse changes in the interest rates charged by the banks when these loans are refinanced.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2560894	usd
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	27911421	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	854615	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	463514	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1706279	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27447907	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	463514	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	854615	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	463514	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	282618	usd
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	786082	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	52401	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	603479	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	335019	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	1389561	usd
CY2023Q1	us-gaap	Supplies Supplies	1252094	usd
CY2022Q1	us-gaap	Supplies Supplies	4177537	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	254668	usd
CY2022Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	727765	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	691070	usd
CY2023Q1	pavs	Prepayments To Technical Provider PrepaymentsToTechnicalProvider	618479	usd
CY2022Q1	pavs	Prepayments To Technical Provider PrepaymentsToTechnicalProvider	669481	usd
CY2022Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	560155	usd
CY2022Q1	pavs	Prepayment To Weilanb PrepaymentToWeilanb	448946	usd
CY2022Q1	us-gaap	Trade Receivables Held For Sale Net Not Part Of Disposal Group TradeReceivablesHeldForSaleNetNotPartOfDisposalGroup	408106	usd
CY2023Q1	pavs	Investment Receivables From The Investors InvestmentReceivablesFromTheInvestors	2000000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	263945	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	226173	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4389186	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7909233	usd
CY2022Q1	us-gaap	Collateralized Agreements CollateralizedAgreements	448946	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	15792196	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17621188	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7321924	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6374373	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8470272	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11246815	usd
CY2023	pavs	Depreciation Expense DepreciationExpense	1200000	usd
CY2022	pavs	Depreciation Expense DepreciationExpense	2100000	usd
CY2023	us-gaap	Depreciation Depreciation	1615173	usd
CY2022	us-gaap	Depreciation Depreciation	1553399	usd
CY2021	us-gaap	Depreciation Depreciation	849454	usd
CY2023	pavs	Capitalized Depreciation In Inventories CapitalizedDepreciationInInventories	278111	usd
CY2022	pavs	Capitalized Depreciation In Inventories CapitalizedDepreciationInInventories	621654	usd
CY2021	pavs	Capitalized Depreciation In Inventories CapitalizedDepreciationInInventories	589610	usd
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	267719	usd
CY2022	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	505969	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	841421	usd
CY2022Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	910808	usd
CY2023Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	8149366	usd
CY2022Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	8822973	usd
CY2023Q1	pavs	Finite Lived Proprietary Technology Gross FiniteLivedProprietaryTechnologyGross	1900000	usd
CY2023Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	10187	usd
CY2022Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	11027	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1041799	usd
CY2022Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	1127710	usd
CY2023Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	11942773	usd
CY2022Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	10872518	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	2496518	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	771113	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9446255	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10101405	usd
CY2023Q1	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset	83520	usd
CY2023	pavs	Right Use Of Land Square Meters RightUseOfLandSquareMeters	12120	pure
CY2022Q1	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset	93140	usd
CY2022	pavs	Right Use Of Land Square Meters RightUseOfLandSquareMeters	12120	pure
CY2023Q1	us-gaap	Sale Leaseback Transaction Transaction Costs Financing Activities SaleLeasebackTransactionTransactionCostsFinancingActivities	1900000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1763779	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	633807	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31425	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2132482	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2132482	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2132482	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2132482	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	916327	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9446255	usd
CY2023Q1	us-gaap	Goodwill Goodwill	6455781	usd
CY2022Q1	us-gaap	Goodwill Goodwill	10084201	usd
CY2022Q1	us-gaap	Goodwill Gross GoodwillGross	10084201	usd
CY2021Q1	us-gaap	Goodwill Gross GoodwillGross	162832	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5184036	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	20237015	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	168555	usd
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	7872696	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	10309745	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-771205	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-5901	usd
CY2023Q1	us-gaap	Goodwill Goodwill	6455781	usd
CY2022Q1	us-gaap	Goodwill Goodwill	10084201	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	10309745	usd
CY2023Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	2138273	usd
CY2022Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	5485325	usd
CY2023Q1	pavs	Prepayment Of Celebrity Endorsement Fee PrepaymentOfCelebrityEndorsementFee	43657	usd
CY2022Q1	pavs	Prepayment Of Celebrity Endorsement Fee PrepaymentOfCelebrityEndorsementFee	141774	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2181930	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5627099	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	5060149	usd
CY2022Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	3310906	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	46485	usd
CY2022Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	130439	usd
CY2022Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	28423	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	5106634	usd
CY2022Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3469768	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2241076	usd
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2268360	usd
CY2022	pavs	Description Of Loan Agreement DescriptionOfLoanAgreement	In addition, the Company entered into a loan agreement of $1,065,238 (RMB 7.0 million) bearing interest rate at LPR plus 0.75% on June 9, 2021 and repaid it on June 5, 2022.
CY2023Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	1259620	usd
CY2022Q1	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	2169355	usd
CY2023	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	72303	usd
CY2022	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	85993	usd
CY2021	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	111790	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1086231	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	778423	usd
CY2023	pavs	Equity Method Investsment Ownership Percentage EquityMethodInvestsmentOwnershipPercentage	1	pure
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0005
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	77223100	shares
CY2019Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	223100	shares
	pavs	Ordinary Share Issued OrdinaryShareIssued	5100000	shares
	pavs	Total Purchase Consideration Amounted TotalPurchaseConsiderationAmounted	10965703	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	10725700	usd
CY2021Q1	us-gaap	Shares Issued SharesIssued	381580	shares
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	778423	usd
CY2021Q2	pavs	Total Consideration Amount TotalConsiderationAmount	351796	usd
CY2021Q2	pavs	Total Consideration Amount TotalConsiderationAmount	2157600	usd
CY2021Q2	pavs	Net Proceeds NetProceeds	2157600	usd
CY2021Q4	pavs	Total Consideration Amount TotalConsiderationAmount	99843	usd
CY2021Q4	pavs	Equity Method Investsment Ownership Percentage EquityMethodInvestsmentOwnershipPercentage	0.70	pure
CY2021Q4	pavs	Consideration Amount ConsiderationAmount	103000000	cny
CY2021Q4	pavs	Consideration Amount ConsiderationAmount	16100000	usd
CY2021Q4	pavs	Total Consideration Amount TotalConsiderationAmount	48000000	cny
CY2021Q4	pavs	Total Consideration Amount TotalConsiderationAmount	7500000	usd
CY2021Q4	pavs	Aggregate Share AggregateShare	4200000	shares
CY2021Q4	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	3736320	usd
CY2021Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	0.0005	usd
CY2021Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	50000	shares
CY2021Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	90000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0.0005	usd
CY2022Q1	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	634592	usd
CY2022Q1	pavs	Net Proceeds NetProceeds	10000000	usd
CY2022Q1	pavs	Total Purchase Consideration Amounted TotalPurchaseConsiderationAmounted	12000000	usd
CY2022Q1	pavs	Total Consideration Amount TotalConsiderationAmount	8000000	usd
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10000000	shares
CY2022Q1	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	10000000	usd
CY2022Q1	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	3560000	usd
CY2022Q1	pavs	Total Consideration Amount TotalConsiderationAmount	6720000	usd
CY2022Q1	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	6720000	usd
CY2022Q4	pavs	Companys Ordinary Shares Description CompanysOrdinarySharesDescription	a Share Consolidation of the Company’s ordinary shares at a ratio of one-for-twenty (the “Share Consolidation”) was effected as determined by the Board of Directors. At the time the Share Consolidation is effective, our authorized ordinary shares will be consolidated at the same ratio. The authorized share capital of the Company shall be decreased from an authorized share capital of US$50,000 divided into 70,000,000 Class A ordinary shares, par value US$0.0005 each, 20,000,000 Class B ordinary shares, par value US$0.0005 each, and 10,000,000 preferred shares with a par value of US$0.0005 each to an authorized share capital of US$50,000 divided into 3,500,000 Class A ordinary shares, par value US$0.01 each, 1,000,000 Class B ordinary shares, par value US$0.01 each, and 500,000 preferred shares, par value US$0.01 each.
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2
CY2022Q4	pavs	Gross Proceeds GrossProceeds	6000000	usd
CY2022Q1	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest Prior To Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestPriorToDisposal	1	pure
CY2022Q1	pavs	Consideration Amount ConsiderationAmount	6000000	usd
CY2022Q1	us-gaap	Compensation And Benefits Trust CompensationAndBenefitsTrust	7081250	usd
CY2023	pavs	Statutory Surplus Reserve Percentage Description StatutorySurplusReservePercentageDescription	Appropriations to the statutory surplus reserve are required to be at least 10% of the after-tax net income determined in accordance with PRC GAAP until the reserve is equal to 50% of the entity’s registered capital. Appropriations to the discretionary surplus reserve are made at the discretion of the Board of Directors. In 2019, $56,077 was appropriated by Fujian Happiness to the statutory surplus reserve and the statutory reserve reached 50% of its registered capital. In 2020, no statutory surplus was appropriated.
CY2021Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5558669	usd
CY2023	us-gaap	Statutory Accounting Practices Prescribed Practice Amount StatutoryAccountingPracticesPrescribedPracticeAmount	7622765	usd
CY2022	us-gaap	Statutory Accounting Practices Prescribed Practice Amount StatutoryAccountingPracticesPrescribedPracticeAmount	7622765	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	300000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.12
	pavs	Contractual Life In Days Granted ContractualLifeInDaysGranted	P45Y
	pavs	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised	-300000	shares
	pavs	Share Based Compensation Arrangements By Share Based Payment Award Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisePrice	5.12
	pavs	Contractual Life In Days Expired ContractualLifeInDaysExpired	P45Y
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2020Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.6
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P4Y7M6D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2021Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.6
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P3Y7M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2022Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.6
CY2022Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P2Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	160000	shares
CY2023Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Optionsoutstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherOptionsoutstandingWeightedAverageExercisePrices	6.6
CY2023Q1	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOne	P1Y7M6D
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	effective from January 1, 2008, both domestically-owned enterprises and foreign-invested enterprises are subject to a uniform tax rate of 25% while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. EIT grants preferential tax treatment to High and New Technology Enterprises (“HNTEs”). Under this preferential tax treatment, HNTEs are entitled to an income tax rate of 15%, subject to a requirement that they re-apply for HNTE status every three years. Fujian Happiness, the Company’s main operating entity in PRC, was approved as HNTEs and is entitled to a reduced income tax rate of 15% from December 2019 to December 2022.
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.10	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.10	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.10	pure
CY2023	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	0.022	pure
CY2022	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	0.027	pure
CY2021	pavs	Effective Income Tax Rate Reconciliation Deduction EffectiveIncomeTaxRateReconciliationDeduction	0.074	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.177	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.224	pure
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	363493	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	195678	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	959384	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3093587	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3921905	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3457080	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3726227	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	959384	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20634308	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4402633	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	20634308	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	606141	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3796492	usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4402633	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16231675	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4402633	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	20634308	usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4402633	usd
CY2023	pavs	Intangible Assets Arising From Acquisition IntangibleAssetsArisingFromAcquisition	-1514060	usd
CY2022	pavs	Intangible Assets Arising From Acquisition IntangibleAssetsArisingFromAcquisition	-2079986	usd
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-1514060	usd
CY2022Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-2079986	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1514060	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3796492	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2079986	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	57167	usd
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	15078	usd
CY2023Q1	pavs	Value Added Tax Payable ValueAddedTaxPayable	31600	usd
CY2022Q1	pavs	Value Added Tax Payable ValueAddedTaxPayable	2189	usd
CY2023Q1	pavs	Other Tax Payables OtherTaxPayables	54593	usd
CY2022Q1	pavs	Other Tax Payables OtherTaxPayables	19958	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	143360	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	37225	usd
CY2021Q4	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	7500000	usd
CY2021Q4	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	48000000	cny
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	9100000	usd
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	60000000	cny
CY2022Q1	pavs	Over Paid OverPaid	12000000	cny
CY2022Q1	pavs	Over Paid OverPaid	1900000	usd
CY2022	us-gaap	Exchange Fees ExchangeFees	300000	usd
CY2022Q1	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest Prior To Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestPriorToDisposal	1	pure
CY2022Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	12000000	usd
CY2023	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	383376	usd
CY2022	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	95932	usd
CY2023	us-gaap	Risks And Uncertainties In Entitys Business RisksAndUncertaintiesInEntitysBusiness	Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.
CY2023	pavs	Total Revenues Percentage TotalRevenuesPercentage	0.10	pure
CY2022	pavs	Total Revenues Percentage TotalRevenuesPercentage	0.10	pure
CY2022Q1	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.259	pure
CY2021Q1	us-gaap	Percentage Of Fifo Inventory PercentageOfFIFOInventory	0.168	pure
CY2022Q1	us-gaap	Due To Correspondent Brokers DueToCorrespondentBrokers	4300000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet		usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.63
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26160270	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40485912	shares
CY2021	pavs	Statutory Reserve StatutoryReserve		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2023	pavs	Share Consolidation ShareConsolidation		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2021	pavs	Goodwill Impairment Loss1 GoodwillImpairmentLoss1		usd
CY2021	pavs	Gain Loss On Sale Of Property Plants Equipment GainLossOnSaleOFPropertyPlantsEquipment		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	pavs	Business Acquisitions Of Hekangyuan BusinessAcquisitionsOfHekangyuan		usd
CY2021	pavs	Business Acquisitions Of Hekangyuan BusinessAcquisitionsOfHekangyuan		usd
CY2023	pavs	Deposits Return From Shennong DepositsReturnFromShennong		usd
CY2021	pavs	Deposits Return From Shennong DepositsReturnFromShennong		usd
CY2023	pavs	Purchase Of Daji PurchaseOfDAJI		usd
CY2022	pavs	Purchase Of Daji PurchaseOfDAJI		usd
CY2023	pavs	Deposits Paid For Business Acquisitions DepositsPaidForBusinessAcquisitions		usd
CY2022	pavs	Deposits Paid For Business Acquisitions DepositsPaidForBusinessAcquisitions		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends		usd
CY2023	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2023Q1	us-gaap	Reorganization Value Net Realizable Value Of Asset Dispositions ReorganizationValueNetRealizableValueOfAssetDispositions		usd
CY2022Q1	us-gaap	Reorganization Value Net Realizable Value Of Asset Dispositions ReorganizationValueNetRealizableValueOfAssetDispositions		usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2023Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable		usd
CY2023Q1	pavs	Prepayment To Weilanb PrepaymentToWeilanb		usd
CY2023Q1	us-gaap	Trade Receivables Held For Sale Net Not Part Of Disposal Group TradeReceivablesHeldForSaleNetNotPartOfDisposalGroup		usd
CY2022Q1	pavs	Investment Receivables From The Investors InvestmentReceivablesFromTheInvestors		usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive		usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1		usd
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent		usd
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber		shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
CY2020Q1	pavs	Contractual Life In Days Options Outstanding Beginning Balance ContractualLifeInDaysOptionsOutstandingBeginningBalance
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber		shares
CY2020Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	pavs	Intrinsic Value Option Granted IntrinsicValueOptionGranted		usd
	pavs	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Cancelled1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndCancelled1		shares
	pavs	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited And Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedAndCancelled
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
	pavs	Intrinsic Value Option Forfeited IntrinsicValueOptionForfeited		usd
	pavs	Intrinsic Value Option Expired IntrinsicValueOptionExpired		usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares		shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022Q1	pavs	Contractual Life In Days Options Outstanding ContractualLifeInDaysOptionsOutstanding
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber		shares
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
CY2022Q1	pavs	Contractual Life In Days Options Exercisable Ending Balance ContractualLifeInDaysOptionsExercisableEndingBalance
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Granted Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantedPrice
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Granted Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedWeightedAverageRemainingContractualTerms
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Granted SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageForfeited
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Forfeited Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedWeightedAverageRemainingContractualTerms
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueForfeited		usd
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod		shares
CY2021	pavs	Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Exercised In Periods ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsExercisedInPeriods
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Exercised Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageRemainingContractualTerms
CY2021	pavs	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercised SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercised		usd
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2021Q1	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2020Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	pavs	Write Off WriteOff		usd
CY2022	pavs	Write Off WriteOff		usd
CY2021	pavs	Write Off WriteOff		usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount		usd
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021	pavs	Intangible Assets Arising From Acquisition IntangibleAssetsArisingFromAcquisition		usd
CY2021Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	353001
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001751876

Files In Submission

Name	View Source	Status
0001213900-23-060263-index-headers.html	Edgar Link	pending
0001213900-23-060263-index.html	Edgar Link	pending
0001213900-23-060263.txt	Edgar Link	pending
0001213900-23-060263-xbrl.zip	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-2_001.jpg	Edgar Link	pending
ex23-2_002.jpg	Edgar Link	pending
ex23-2_003.jpg	Edgar Link	pending
ex99-1_001.jpg	Edgar Link	pending
ex99-1_002.jpg	Edgar Link	pending
ex99-1_003.jpg	Edgar Link	pending
f20f2023ex12-1_paranovus.htm	Edgar Link	pending
f20f2023ex12-2_paranovus.htm	Edgar Link	pending
f20f2023ex13-1_paranovus.htm	Edgar Link	pending
f20f2023ex23-1_paranovus.htm	Edgar Link	pending
f20f2023ex23-2_paranovus.htm	Edgar Link	pending
f20f2023ex8-1_paranovus.htm	Edgar Link	pending
f20f2023ex99-1_paranovus.htm	Edgar Link	pending
f20f2023_paranovus.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pavs-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pavs-20230331_cal.xml	Edgar Link	unprocessable
pavs-20230331_def.xml	Edgar Link	unprocessable
pavs-20230331_lab.xml	Edgar Link	unprocessable
pavs-20230331_pre.xml	Edgar Link	unprocessable
f20f2023_paranovus_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs

2023 Q1 Form 20-F Financial Statement

#000121390023060263 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAVS Paranovus Entertainment Technology Ltd. Stock $pavs

2023 Q1 Form 20-F Financial Statement

#000121390023060263 Filed on July 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PAVS
Paranovus Entertainment Technology Ltd. Stock $pavs